GoodRx Holdings (GDRX) Debt/EBITDA US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
Debt/EBITDA | 1.03 | -4.97 | -10.6 | -0.62 | 0.24 | 1.62 | |||
Changes by years, y/y, % | -77% | -585% | +113% | -94% | -139% | -50.4% |
GoodRx Holdings. Debt/EBITDA
GoodRx Holdings. Debt/EBITDA, changes, %
GoodRx Holdings (GDRX) Debt/EBITDA US GAAP (quarter values) |
||||||||
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
Debt/EBITDA | -0.69 | -0.49 | -0.85 | 0.37 | 1.62 | 1.62 | ||
Changes by years, y/y, % | -63% | +31% | +83% | -160% | -336% | |||
Changes by quarters, q/q, % | +12% | -29% | +75% | -144% | +336% |